As shown in Figure S1A,B, FGF1 showed a robust glucose homeostasis profile, lowed the plasma insulin of db/db mice and did not cause hypoglycaemia and changeable plasma glucagon after chronic administration (Figure S2). This evidence concerns the gene GCG and Hypoglycemia.